US pharma firm to build manufacturing plant in Ireland

US pharma firm Aerie has earmarked proceeds from the $125m it has raised in stock market sales for the construction of an Irish manufacturing facility.

The plant is expected to serve the $1bn company's international and US markets, the Irish Independent reports.

Aerie moved its intellectual property to Irish shores early last year, and its planned manufacturing plant will form part of its broader supply chain strategy.

Aerie Pharmaceuticals deals with the discovery, development and commercialisation of therapies used in the treatment of glaucoma and other eye diseases.